Boston Scientific Corporation
BSX · Healthcare · · USDFahodi Score SELL Short-term (Swing)
39
/ 100
Technical
50
Trend & RS
32
Momentum
30
Fundamental (0%)
56
Macro
22
Liquidity
57
| Component | Score | Weight |
|---|---|---|
| Technical | 50.0 | 40% |
| Trend & RS | 32.0 | 20% |
| Momentum | 30.5 | 20% |
| Fundamental | 55.6 | 0% |
| Macro | 22.5 | 15% |
| Liquidity | 57.0 | 5% |
Trade Setup
| Entry | 44.64 |
| Stop Loss | 41.06 (8.0%) |
| Target 1 (1:1) | 48.22 (+8.0%) |
| Target 2 (2:1) | 51.80 (+16.0%) |
| ATR(14) | 1.79 (4.0%) |
| Risk per Share | 3.58 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 74.0 | +0.96 | |
| Momentum | 30.5 | -0.78 | |
| Quality | 42.1 | -0.32 | |
| Composite | 48.8 | ||
Quality Scores
Piotroski F-Score
5
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 18.8 | 22.0 | -14% below |
| P/B Ratio | 2.5 | 4.0 | Below |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
29.26
vs
Market Price
44.64
Upside
-34.5%
| Margin of Safety | -52.6% |
| Stage 1 PV (5yr FCF) | 11,309,700,396 |
| Terminal Value PV | 31,097,639,599 |
| Total Enterprise Value | 42,407,339,995 |
Assumptions
| Base FCF | 2,748,201,348 |
| Growth Rate (5yr) | 2.0% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
23.68%
Full Kelly
11.84%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 39/100. Estimated win rate 52%, avg win 7.3%, avg loss 4.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary BUY
2
Bullish Signals
2
Bearish Signals
51.61
RSI(14)
-0.0091
MACD
Relative Strength (RS) WEAK RS
5
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (-4.5% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | No (55d since high) |
| Sector Outperformance | -22.4% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
WEAK RS:
Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 51.61 | NEUTRAL |
| Macd | -0.0091 | BULLISH |
| Ma Cross | 44.41 / 55.6 | DEATH CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.11x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 105.65 |
| Bollinger Upper | 46.69 |
| SMA(200) | 55.6 |
| SMA(50) | 44.41 |
| SMA(20) | 44.21 |
| Current Price | 44.64 |
| Bollinger Lower | 41.74 |
| 52-Week Low | 39.57 |
| ATR(14) | 1.79 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKDOWN
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 0.0 |
Markdown: 2.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 1.11x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 1.12x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.93x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.71x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.11x | Normal bar — no special VSA pattern |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 43.27 | Below Kijun |
| Kijun-sen (26) | 43.27 | Base line |
| Senkou A | 43.27 | Leading span A |
| Senkou B | 44.80 | Leading span B |
| Cloud | 43.27 – 44.80 | Bearish (Red) |
| Price vs Cloud | 44.64 | Inside Cloud |
| Chikou Span | 43.23 | Bullish |
| Alignment Score | 1/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
1 bars
Momentum:
BULLISH FADING
BB: 41.74 – 46.69 | KC: 41.64 – 46.78
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Hidden Bullish | MACD | 5 |
Anchored VWAP
VWAP: 43.31
Anchor: 2026-10-28 (52w Low)
ABOVE AVWAP
+3.1%
Heikin-Ashi Trend
BULLISH
Full data via /api/advanced/BSX
Valuation
| Metric | Value |
|---|---|
| Market Cap | 64.70B |
| P/E (TTM) | 18.84 |
| Forward P/E | N/A |
| P/B | 2.52 |
| EPS | 2.37 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 1.4% |
| Profit Margin | 16.6% |
| ROE | 14.1% |
| Debt/Equity | 46.20 |
| Current Ratio | 1.36 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 0.58 |
Trading Data
44.64
Open
44.64
Day High
44.64
Day Low
22.48M
Volume (1.1x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)